Serum fibroblast growth factor 21 in overweight and obese Thai children and adolescents: Its relation to glucose metabolism and its change after glucose loading

Clinical Endocrinology

Volumn 83, Issue 6, 2015, Pages 820-827

  Korwutthikulrangsri, Manassawee ^a   Mahachoklertwattana, Pat ^a   Chanprasertyothin, Suwannee ^a   Pongratanakul, Sarunyu ^a   Poomthavorn, Preamrudee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; FIBROBLAST GROWTH FACTOR;

ADOLESCENT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TERTIARY CARE CENTER; BLOOD; GLUCOSE INTOLERANCE; METABOLISM; PHYSIOLOGY; THAILAND;

ADOLESCENT; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; OVERWEIGHT; THAILAND;

EID: 84930031746     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12808     Document Type: Article

References (38)

1. Ode, K.L., Frohnert, B.I., &, Nathan, B.M., (2009) Identification and treatment of metabolic complications in pediatric obesity. Reviews in Endocrine & Metabolic Disorders, 10, 167-188.
2. Misra, A., &, Khurana, L., (2008) Obesity and the metabolic syndrome in developing countries. The Journal of Clinical Endocrinology and Metabolism, 93, S9-S30.
3. Kharitonenkov, A., Shiyanova, T.L., Koester, A., et al,. (2005) FGF-21 as a novel metabolic regulator. The Journal of Clinical Investigation, 115, 1627-1635.
4. Badman, M.K., Pissios, P., Kennedy, A.R., et al,. (2007) Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metabolism, 5, 426-437.
5. Mai, K., Andres, J., Biedasek, K., et al,. (2009) Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes, 58, 1532-1538.
6. Zhang, X., Yeung, D.C., Karpisek, M., et al,. (2008) Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes, 57, 1246-1253.
7. Keipert, S., Ost, M., Johann, K., et al,. (2014) Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. American Journal of Physiology. Endocrinology and Metabolism, 306, E469-E482.
8. Coskun, T., Bina, H.A., Schneider, M.A., et al,. (2008) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology, 149, 6018-6027.
9. Li, L., Yang, G., Ning, H., et al,. (2008) Plasma FGF-21 levels in type 2 diabetic patients with ketosis. Diabetes Research and Clinical Practice, 82, 209-213.
10. Lin, Z., Gong, Q., Wu, C., et al,. (2012) Dynamic change of serum FGF21 levels in response to glucose challenge in human. The Journal of Clinical Endocrinology and Metabolism, 97, E1224-E1228.
11. Semba, R.D., Sun, K., Egan, J.M., et al,. (2012) Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging. The Journal of Clinical Endocrinology and Metabolism, 97, 1375-1382.
12. Reinehr, T., Woelfle, J., Wunsch, R., et al,. (2012) Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. The Journal of Clinical Endocrinology and Metabolism, 97, 2143-2150.
13. Giannini, C., Feldstein, A.E., Santoro, N., et al,. (2013) Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage. The Journal of Clinical Endocrinology and Metabolism, 98, 2993-3000.
14. Ko, B.J., Kim, S.M., Park, K.H., et al,. (2014) Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children. International Journal of Obesity, 38, 1497-1502.
15. Hanks, L.J., Casazza, K., Ashraf, A.P., et al,. (2015) Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females. Clinical Endocrinology, 82, 550-556.
16. Bisgaard, A., Sørensen, K., Johannsen, T.H., et al,. (2014) Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents. International Journal of Pediatric Endocrinology, 2014, 7.
17. Holland, W.L., Adams, A.C., Brozinick, J.T., et al,. (2013) An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metabolism, 17, 790-797.
18. Poomthavorn, P., Nantarakchaikul, P., Mahachoklertwattana, P., et al,. (2014) Effects of correction of vitamin D insufficiency on serum osteocalcin and glucose metabolism in obese children. Clinical Endocrinology, 80, 516-523.
19. WHO (2007) Growth reference data for 5-19 years. 2007 WHO reference. Available from: http://www.who.int/growthref/en/ (accessed 4 May 2014).
20. Department of Health, Ministry of Public Health (2000) Reference for Weight, Height and Nutritional Indices in Thais Aged 1 Day to 19 Years. Department of Health, Ministry of Public Health, Bangkok, Thailand.
21. Yan, W., Yao, H., Dai, J., et al,. (2008) Waist circumference cutoff points in school-aged Chinese Han and Uygur children. Obesity, 16, 1687-1692.
22. Marshall, W.A., &, Tanner, J.M., (1970) Variations in the pattern of pubertal changes in boys. Archives of Disease in Childhood, 45, 13-23.
23. Marshall, W.A., &, Tanner, J.M., (1969) Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood, 44, 291-303.
24. Lim, J.S., Hwang, J.S., Lee, J.A., et al,. (2009) Cross-calibration of multi-frequency bioelectrical impedance analysis with eight-point tactile electrodes and dual-energy X-ray absorptiometry for assessment of body composition in healthy children aged 6-18 years. Pediatrics International, 51, 263-268.
25. Matsuda, M., &, DeFronzo, R.A., (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470.
26. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al,. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
27. Albareda, M., Rodríguez-Espinosa, J., Murugo, M., et al,. (2000) Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia, 43, 1507-1511.
28. Reaven, G.M., Chen, Y.D., Hollenbeck, C.B., et al,. (1993) Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. The Journal of Clinical Endocrinology and Metabolism, 76, 44-48.
29. Craig, M.E., Hattersley, A., &, Donaghue, K., (2006) ISPAD Clinical Practice Consensus Guidelines 2006-2007. Definition, epidemiology and classification. Pediatric Diabetes, 7, 343-351.
30. Mraz, M., Bartlova, M., Lacinova, Z., et al,. (2009) Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clinical Endocrinology, 71, 369-375.
31. Zhang, M., Liu, Y., Xiong, Z.Y., et al,. (2013) Changes of plasma fibroblast growth factor-21 (FGF-21) in oral glucose tolerance test and effects of metformin on FGF-21 levels in type 2 diabetes mellitus. Endokrynologia Polska, 64, 220-224.
32. Fisher, F.M., Chui, P.C., Antonellis, P.J., et al,. (2010) Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes, 59, 2781-2789.
33. Toledo-Corral, C.M., Alderete, T.L., Richey, J., et al,. (2015) Fasting, post-OGTT challenge, and nocturnal free fatty acids in prediabetic versus normal glucose tolerant overweight and obese Latino adolescents. Acta Diabetologica, 52, 277-284.
34. Mai, K., Bobbert, T., Groth, C., et al,. (2010) Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin. American Journal of Physiology. Endocrinology and Metabolism, 299, E126-E130.
35. Eto, K., Tumenbayar, B., Nagashima, S., et al,. (2010) Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes. Diabetes Research and Clinical Practice, 89, 52-57.
36. Vienberg, S.G., Brøns, C., Nilsson, E., et al,. (2012) Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls. European Journal of Endocrinology, 167, 49-57.
37. Uebanso, T., Taketani, Y., Yamamoto, H., et al,. (2011) Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor? PLoS ONE, 6, e22976.
38. Tura, A., Pacini, G., Winhofer, Y., et al,. (2012) Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes. Diabetic Medicine, 29, 351-358.